SARS-CoV-2 Pandemic Impacts on NASA Ground Operations to Protect ISS Astronauts.
J Allergy Clin Immunol Pract
; 8(10): 3247-3250, 2020.
Article
em En
| MEDLINE
| ID: mdl-32971311
ABSTRACT
NASA implements required medical tests and clinical monitoring to ensure the health and safety of its astronauts. These measures include a pre-launch quarantine to mitigate the risk of infectious diseases. During space missions, most astronauts experience perturbations to their immune system that manifest as a detectable secondary immunodeficiency. On return to Earth, after the stress of re-entry and landing, astronauts would be most vulnerable to infectious disease. In April 2020, a crew returned from International Space Station to NASA Johnson Space Center in Houston, Texas, during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Post-flight quarantine protocols (both crew and contacts) were enhanced to protect this crew from SARS-CoV-2. In addition, specific additional clinical monitoring was performed to determine post-flight immunocompetence. Given that coronavirus disease 2019 (COVID-19) prognosis is more severe for the immunocompromised, a countermeasures protocol for spaceflight suggested by an international team of scientists could benefit terrestrial patients with secondary immunodeficiency.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Pneumonia Viral
/
Voo Espacial
/
Estresse Fisiológico
/
Quarentena
/
Hospedeiro Imunocomprometido
/
Infecções por Coronavirus
/
Astronautas
/
Pandemias
Tipo de estudo:
Guideline
/
Prognostic_studies
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
J Allergy Clin Immunol Pract
Ano de publicação:
2020
Tipo de documento:
Article